Etiology and management of refractory epilepsies

Nature Clinical Practice Neurology

Volumn 3, Issue 6, 2007, Pages 320-330

  Sisodiya, Sanjay ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; GLYCOPROTEIN P; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN 1; PHENYTOIN; PIRACETAM; SODIUM CHANNEL; STIRIPENTOL; TIAGABINE; VALPROIC ACID; VIGABATRIN;

ANAMNESIS; BLOOD BRAIN BARRIER; DIAGNOSTIC ERROR; DISEASE CONTROL; DRUG EFFICACY; DRUG TARGETING; DRUG USE; ELECTROENCEPHALOGRAPHY; EPILEPSY; FOCAL EPILEPSY; GENE MUTATION; GENETIC ANALYSIS; HEART ARRHYTHMIA; HUMAN; HYPOTHESIS; KETOGENIC DIET; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MEDICAL SPECIALIST; MIGRAINE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; MYOCLONUS EPILEPSY; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANIC; PARASOMNIA; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT REFERRAL; PATIENT SELECTION; PHARMACOGENETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; SYNCOPE; TEMPORAL LOBECTOMY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VESTIBULAR DISORDER;

ANIMALS; ANTICONVULSANTS; EPILEPSY; HUMANS; PRACTICE GUIDELINES;

EID: 34250176921     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0521     Document Type: Review

References (73)

1. Sander JW (2003) The epidemiology of epilepsy revisited. Curr Opin Neurol 16: 165-170
2. Due T et al. (2006) Epilepsy care in the world: Results of an ILAE/ IBE/WHO Global Campaign Against Epilepsy survey. Epilepsia 47: 1225-1231
3. Ndoye NF et al. (2005) Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure 14: 106-111
4. Jacoby A (2002) Stigma, epilepsy, and quality of life. Epilepsy Behav 3 (Suppl 6): S10-S20
5. Tomson T et al. (2005) Sudden unexpected death in epilepsy: A review of incidence and risk factors. Epilepsia 46 (Suppl 11): S54-S61
6. Blume WT et al. (2001) Glossary of descriptive terminology for ictal semiology: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 1212-1218
7. Berg AT (2006) Defining intractable epilepsy. Adv Neurol 97: 5-10
8. Berg AT and Kelly MM (2006) Defining intractability: Comparisons among published definitions. Epilepsia 47: 431-436
9. Mohanraj R and Brodie MJ (2006) Diagnosing refractory epilepsy: Response to sequential treatment schedules. Eur J Neurol 13: 277-282
10. French JA et al. (2004) Efficacy and tolerability of the new antiepileptic drugs II: TreaRment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62: 1261-1273
11. Cross JH et al. (2006) Proposed criteria for referral and evaluation of children for epilepsy surgery: Recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 47: 952-959
12. Spencer SS (2002) When should temporal-lobe epilepsy be treated surgically? Lancet Neurol 1: 375-382
13. Berg AT et al. (2006) How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol 60: 73-79
14. Sillanpaa M and Schmidt D (2006) Natural history of treated childhood-onset epilepsy: Prospective, long-term population-based study. Brain 129: 617-624
15. Kellinghaus C et al. (2004) Specific epileptic syndromes are rare even in tertiary epilepsy centers: A patient-oriented approach to epilepsy classification. Epilepsia 45: 268-275
16. Remy S and Beck H (2006) Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129: 18-35
17. Schmidt D and Loscher W (2005) Drug resistance in epilepsy: Putative neurobiologic and clinical mechanisms. Epilepsia 46: 858-877
18. Kwan P and Brodie MJ (2005) Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 46: 224-235
19. Sisodiya SM et al. (2002) Drug resistance in epilepsy: Expression of drug resistance proteins in common causes of refractory epilepsy. Brain 125: 22-31
20. Loscher W and Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301: 7-14
21. Rizzi M et al. (2002) Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance. J Neurosci 22: 5833-5839
22. Marchi N et al. (2005) A pilot study on brain-to-plasma partition of 10, 11 -dyhydro- 10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. Epilepsia 46: 1613-1619
23. Rambeck B et al. (2006) Comparison of.brain extracellular fluid, brain tissue, cerebrospinall fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 47: 681-694
24. van Vliet EA et al. (2006) Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 47: 672-680
25. Brandt C et al. (2006) The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 24: 202-211
26. Crowe A and Teoh YK (2006) Limited P-glycoprotein mediated efflux for anti-epileptic drugs. J Drug Target 14: 291-300
27. Sisodiya SM and Bates SE (2006) Treatment of drug resistance in epilepsy. one step at a time. Lancet Neurol 5: 380-381
28. Remy S et al. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53: 469-479
29. Jandová K et al. (2006) Carbamazepine-resistance in the epileptic dentate gyrus of human hippocampal slices. Brain 129: 3290-3306
30. A receptors from the human epileptic hippocampal subiculum microtransplanted to Xenopus oocytes. Proc Natl Acad Sci USA 102: 2514-2518
31. Palma E et al. (2006) Anomalous levels of Cl- transporters in the hippocampall subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc Natl Acad Sci USA 103: 8465-8468
32. Fujiwara T (2006) Clinical spectrum of mutations in SCN1A gene: Severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res 70 (Suppl 1): S223-S230
33. Barela AJ et al. (2006) An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability. J Neurosci 26: 2714-2723
34. Quilichini PP et al. (2006) Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels. Epilepsia 47: 704-716
35. Yu FH et al. (2006) Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9: 1142-1149
36. Schmidt D et al. (2004) Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: A review of current clinical experience. Epilepsia 45: 179-186
37. Thom M et al. (2007) Epilepsy. In Greenfield's Neuropathology edn 8 (Eds Love S et al.) London: Edward Arnold (Publishers) Ltd, in press
38. Becker AJ et al. (2003) Correlated stage- and subfield-associated hippocampal gene expression patterns in experimental and human temporal lobe epilepsy. Eur J Neurosci 18: 2792-2802
39. Cossart R et al. (2005) Multiple facets of GABAergic neurons and synapses: Multiple fates of GABA signalling in epilepsies. Trends Neurosci 28: 108-115
40. Stafstrom CE and Sutula TP (2005) Models of epilepsy in the developing and adult brain: Implications for neuroprotection. Epilepsy Behav 7 (Suppl 3): S18-S24
41. Magloczky Z and Freund TF (2005) Impaired and repaired inhibitory circuits in the epileptic human hippocampus. Trends Neurosci 28: 334-340
42. Tate SK et al. (2005) Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbarnazepine and phenytoin. Proc Natl Acad Sci USA 102: 5507-5512
43. Siddiqui A et al. (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348: 1442-1448
44. Tan NC et al. (2004) Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63: 1090-1092
45. Tan NC et al. (2004) Genetic association studies in epilepsy: "the truth is out there". Epilepsia 45: 1429-1442
46. Stokes T et al. (2004) Clinical Guidelines and Evidence Review for the Epilepsies: Diagnosis and management in adults and children in primary and secondary care. London: Royal College of General Practitioners
47. Scottish Intercollegiate Guidelines Network (online April 2003) 70: Diagnosis and management of epilepsy in adults: A national clinical guideline. [http://www.sign.ac.uk/pdf/sign70.pdf], accessed 25 August 2006
48. Sisodiya SM (2007) Choice of agent in treatment of epilepsy. In Treating Individuals (Ed. Rothwell P) Elsevier: New York, in press
49. Shorvon SD (2006) We live in the age of the clinical guideline. Epilepsia 47: 1091-1093
50. Baulac S et al. (2004) Fever, genes, and epilepsy. Lancet Neurol 3: 421-430
51. Berkovic SF et al. (2006) De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study. Lancet Neurol 5: 488-492
52. Shahwan A et al. (2005) Progressive myoclonic epilepsies: A review of genetic and therapeutic aspects. Lancet Neurol 4: 239-248
53. Jones RM et al. (2006) Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs. Seizure 15: 504-508
54. Williams J et al. (2006) Variability of antiepileptic medication taking behaviour in sudden unexplained death in epilepsy: Hair analysis at autopsy. J Neurol Neurosurg Psychiatry 77: 481-484
55. Mellers JD (2005) The approach to patients with "non-epileptic seizures". Postgrad Med J 81: 498-504
56. Reuber M et al. (2005) Measuring outcome in psychogenic nonepileptic seizures: How relevant is seizure remission? Epilepsia 46: 1788-1795
57. Salmenpera TM and Duncan JS (2005) Imaging in epilepsy. J Neurol Neurosurg Psychiatry 76 (Suppi 3): Siii2-Siii10
58. Von Oertzen J et al. (2002) Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry 73: 643-647
59. Knake S et al. (2005) 3T phased array MRI improves the presurgical evaluation in focal epilepsies: A prospective study. Neurology 65: 1026-1031
60. Uldall P et al. (2006) The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child 91: 219-221
61. Luders H and Schuele SU (2006) Epilepsy surgery in patients with malformations of cortical development. Curr Opin Neurol 19: 169-174
62. Blume WT et al. (2004) Indices of resective surgery effectiveness for intractable nonlesional focal epilepsy. Epilepsia 45: 46-63
63. Duncan JS (1997) Imaging and epilepsy. Brain 120: 339-377
64. Theodore WH (2005) Brain stimulation for epilepsy. Nat Clin Pract Neurol 1: 64-65
65. Henderson CB et al. (2006) Efficacy of the ketogenic diet as a treatment option for epilepsy: Meta-analysis. J Child Neurol 21: 193-198
66. Garriga-Canut M et al. (2006) 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat Neurosci 9: 1382-1387
67. Costantin L et al. (2005) Antiepileptic effects of botulinum neurotoxin E. J Neurosci 25: 1943-1951
68. Haberman RP et al. (2003) Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9: 1076-1080
69. Haberman R et al. (2002) Therapeutic liabilities of in vivo viral vector tropism: Adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol Ther 6: 495-500
70. McCown TJ (2006) Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14: 63-68
71. Guttinger M et al. (2005) Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol 193: 53-64
72. Mormann F et al. (2006) Seizure anticipation: From algorithms to clinical practice. Curr Opin Neurol 19: 187-193
73. Rothman SM et al. (2005) Focal cooling for epilepsy: An alternative therapy that might actually work. Epilepsy Behav 7 214-221